무작위 임상시험의 윤리적ㆍ법적 문제
Ethical and Legal Problems of Randomized Clinical Trials
0
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Human experimentation can be ethically justified when subjects participate on a voluntary basis. Informed consent is required for clinical trials, including randomized clinical trials. Nevertheless, ethical issues arise when subjects are randomly distributed to experimental and control groups in randomized clinical trials. I argue that equipoise as well as informed consent is a condition of randomized clinical trials. Benjamin Freedman distinguishes theoretical equipoise from clinical equipoise. I call the former the “individual physician equipoise” and the latter the “clinical community equipoise.” Under clinical community equipoise, randomized clinical trials are ethically justified because physicians may still provide the best treatment to their patients. The above ethical principle should be applied to placebo-controlled randomized clinical trials. When experimental drugs and placebos are in clinical community equipoise, a trial may be ethically justified. In addition, placebo-controlled randomized clinical trials should be designed with double-blinding. The reason for this requirement is that physicians would cheat their patients without double-blinding. Current FDA regulations in Korea and the US do not sufficiently reflect the above ethical points. Institutional review boards should review their protocols in light of these ethical points. In particular, IRB regulations should reflect the basic ideas of equipoise in randomized clinical trials and double-blinding in placebo-controlled randomized clinical trials.
Abstract
Human experimentation can be ethically justified when subjects participate on a voluntary basis. Informed consent is required for clinical trials, including randomized clinical trials. Nevertheless, ethical issues arise when subjects are randomly distributed to experimental and control groups in randomized clinical trials. I argue that equipoise as well as informed consent is a condition of randomized clinical trials. Benjamin Freedman distinguishes theoretical equipoise from clinical equipoise. I call the former the “individual physician equipoise” and the latter the “clinical community equipoise.” Under clinical community equipoise, randomized clinical trials are ethically justified because physicians may still provide the best treatment to their patients. The above ethical principle should be applied to placebo-controlled randomized clinical trials. When experimental drugs and placebos are in clinical community equipoise, a trial may be ethically justified. In addition, placebo-controlled randomized clinical trials should be designed with double-blinding. The reason for this requirement is that physicians would cheat their patients without double-blinding. Current FDA regulations in Korea and the US do not sufficiently reflect the above ethical points. Institutional review boards should review their protocols in light of these ethical points. In particular, IRB regulations should reflect the basic ideas of equipoise in randomized clinical trials and double-blinding in placebo-controlled randomized clinical trials.
참고문헌 (35)
- Kant I., "Fundamental Principles of the Metaphysic of Morals, In Ethics : History, Theory, and Contemporary Issues", pp.297~ (1998), Oxford University Press
- "식품의약품안전청의 고시인 <의약품 임상시험관리기준>", ~
- 김현철, "임상시험의 법과 윤리", pp.79~ (2007), 이화여자대학교 생명의료법연구소
- "<의약품임상시험관리기준> (2007.5.31) 제17조 제10항", ~ (2007)
- Robert V., "The Basics of Bioethics (2nd edition)", pp.77~79 (2003), Prentice Hall
- 김현철, "Basics of Bioethics", pp.85~87 (2007), Prentice Hall
- Bruce M, "Autonomy and the Refusal of Lifesaving Treatment : Four Cases, Four Senses of Autonomy", The Hastings Center Report August, 11, pp.22~28 (1981)
- "<의약품 임상시험관리기준> (2007.5.31.) 제2조 제9호과 제11호", ~ (2007)
- Hellman S, "Of Mice but Not Men : Problems of Randomized Clinical Trial", New England Journal of Medicine, 324, pp.1585~1589 (1991)
- Emanuel EJ, "Ethical and Regulatory Aspects of Clinical Research : Readings and Commentary", pp.113~116 (2003), Johns Hopkins University Press
- Freedman B, "Equipoise and the Ethics of Clinical Research", New England Journal of Medicine, 317, pp.141~145 (1987)
- Emanuel EJ, "Ethical and Regulatory Aspects of Clinical Research : Readings and Commentary", pp.117~121 (2003), Johns Hopkins University Press
- Gifford. F., "So-Called “Clinical Equipoise”and the Argument from Design", Journal of Medicine and Philosophy, 32(2), pp.136~ (2007)
- Passamani E., "Clinical Trials : Are They Ethical?", New England Journal of Medicine, 324, pp.1589~1591 (1991)
- Munson R., "Intervention and Reflection : Basic Issues in Medical Ethics (8ed)", pp.65~69 (2008), Wadsworth
- Miller FG, "Clinical Equipoise and the Incoherence of Research Ethics", Journal of Medicine and Philosophy, 32(2), pp.153~ (2007)
- Gifford F., "Pulling the Plug on Clinical Equipoise : A Critique of Miller and Weijer", Kennedy Institute of Ethics Journal, 17(3), pp.204~ (2007)
- Gifford F., "Pulling the Plug on Clinical Equipoise", Kennedy Institute of Ethics Journal, 17(3), pp.221~222 (2007)
- Gifford F., "Pulling the Plug on Clinical Equipoise", Kennedy Institute of Ethics Journal, pp.223~ (2007)
- Veatch RM, "The Irrelevance of Equipoise", Journal of Medicine and Philosophy, 32(2), pp.167~183 (2007)
- Gifford F, "Pulling the Plug on Clinical Equipoise", Kennedy Institute of Ethics Journal, pp.211~ (2007)
- Gifford F., "So-Called “Clinical Equipoise”and the Argument from Design", pp.148~ (2007)
- Miller P, "Rehabilitating Equipoise", Kennedy Institute of Ethics Journal, 13, pp.93~118 (2003)
- Rothman KJ, "The Continuing Unethical Use of Placebo Controls", New England Journal of Medicine, 331, pp.394~398 (1994)
- Emanuel EJ, "Ethical and Regulatory Aspects of Clinical Research : Readings and Commentary", pp.127~130 (2003), Johns Hopkins University Press
- Freedman B., "Placebo-Controlled Trials and the Logic of Clinical Purpose", IRB : A Reveiw of Human Subjects Research, 12(6), pp.1~6 (1990)
- Emanuel EJ, "Ethical and Regulatory Aspects of Clinical Research : Readings and Commentary", pp.130~136 (2003), Johns Hopkins University Press
- Emanuel EJ, "The Ethics of Placebo-Controlled Trials : A Middle Ground", New England Journal of Medicine, 345, pp.915~919 (2001)
- Emanuel EJ, "Ethical and Regulatory Aspects of Clinical Research : Readings and Commentary", pp.140~143 (2003), Johns Hopkins University Press
- Gottlieb S., "FDA Rules Hinder Cancer Vaccines", On the Issues. December 1, 2002, ~ (2002)
- Miller FG, "Ethical Assessment of Industry-Sponsored Clinical Trials", Chest, 121, pp.1337~1342 (2002)
- Temple R, "Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments, Part 1 : Ethical and Scientific Issues", Annals of Internal Medicine, 133, pp.455~463 (2000)
- Emanuel EJ, "Ethical and Regulatory Aspects of Clinical Research : Readings and Commentary", pp.137~139 (2003), Johns Hopkins University Press
- "Ethical and Regulatory Aspects of Clinical Research : Readings and Commentary" (2003)[URL]